Results 71 to 80 of about 38,782 (264)

Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

open access: yesAnnals of Intensive Care, 2022
Key Points The most interesting findings were that most patients showed an improvement in their DLCO at 3, 6, and 12 months, and all patients but one who normalized their DLCO did not deteriorate afterwards. Only 11% of patients had persistent impairment
Guillaume Eberst   +19 more
doaj   +1 more source

Hypersensitivity Pneumonitis Associated with Environmental Mycobacteria [PDF]

open access: yes, 2005
A previously healthy man working as a machine operator in an automotive factory developed respiratory symptoms. Medical evaluation showed abnormal pulmonary function tests, a lung biopsy showed hypersensitivity pneumonitis, and his illness was traced to ...
Akshay Sood   +7 more
core   +2 more sources

C26. Efeito do tabagismo na capacidade de difusão pulmonar nos fumadores assintomáticos

open access: yesRevista Portuguesa de Pneumologia, 2003
As alterações enfisematosas parecem ser a primeira repercussão pulmonar estrutural directamente relacionada com o tabagismo. A identificação de parâmetros funcionais respiratórios que permitam detectar precocemente estas lesões contribui para a ...
Sandra André   +4 more
doaj   +1 more source

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. [PDF]

open access: yes, 2017
Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial pneumonia of unknown etiology, primarily affects older adults and leads to a progressive decline in lung function and quality of life.
Collard, Harold R, Oldham, Justin M
core   +2 more sources

Lung diffusing capacity for nitric oxide and carbon monoxide following mild‐to‐severe COVID‐19

open access: yesPhysiological Reports, 2021
A decreased lung diffusing capacity for carbon monoxide (DLCO) has been reported in a variable proportion of subjects over the first 3 months of recovery from severe coronavirus disease 2019 (COVID‐19).
Giovanni Barisione, Vito Brusasco
doaj   +1 more source

Smoking in Systemic Sclerosis: a Longitudinal European Scleroderma Trials and Research Group Study [PDF]

open access: yes, 2018
Data on the role of tobacco exposure in systemic sclerosis (SSc) severity and progression are scarce. We aimed to assess the effects of smoking on the evolution of pulmonary and skin manifestations in the EUSTAR ...
Airó, Paolo   +25 more
core   +5 more sources

An Integrated Assessment Approach for Socio‐Economic Implications of the Desert Locust in Eastern Africa

open access: yesEarth's Future
Desert locust (Schistocerca gregaria) infestations cause significant damage to crops and pastureland, impeding food security and livelihoods globally.
Bonoukpoè Mawuko Sokame   +10 more
doaj   +1 more source

Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy [PDF]

open access: yes, 2015
open11siBackground Chronic, progressive respiratory symptoms are associated with great psychological and emotional impact in patients suffering from interstitial lung disease (ILD).
CERRI, Stefania   +10 more
core   +1 more source

FVC/DLCO identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD

open access: yesEuropean Journal of Medical Research, 2023
Background Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD). However, it is unknown whether the ratio of forced vital capacity (FVC) to diffusing lung capacity for carbon monoxide (DLCO) can identify PH
Yuer Li   +9 more
doaj   +1 more source

A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset. [PDF]

open access: yes, 2012
OBJECTIVE: A prospective observational study of mycophenolate mofetil (MMF) treatment in patients with diffuse progressive cutaneous systemic sclerosis (SSc) of recent onset.
Jimenez, Sergio A.   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy